|
Disease control/elimination |
 |
 |
|
Antibiotics can be used to treat people with meningococcal disease, but early treatment is very important. In some situations, chemoprophylaxis of contacts can be used; however, as 5%–15% of children and young adults carry meningococci in the nose and throat, chemoprophylaxis might be of little value for the control of most endemic and epidemic disease. Immunization is the only rational approach to the control of meningococcal disease. |
|
|
Disease control/elimination |
|
|
|
Please enter your text here |
|
Disease control/elimination |
|
|
|
Recognizing the heavy burden of pneumococcal disease, occurring in young children, and the safety and efficacy of PCV in this age group, WHO recommends the inclusion of PCVs in childhood immunization programmes worldwide. In particular, countries with childhood mortality rate of >50 deaths/1000 births should make the introduction of PCV a high priority.
Since Pneumococcal diseases are responsible for considerable proportion of morbidity and mortality among under five years children in the Eastern Mediterranean Region, introduction of pneumococcal vaccine and achieving high vaccination coverage is an important tool towards achieving the Millennium Development Goal number 4 (MDG4). Accelerating the introduction of the vaccine in the countries in the region is deemed necessary.
By May 2012 PCV has been introduced in nine countries in the Eastern Mediterranean Region, which account for only 12.3% of the annual births in the Region. The average regional coverage of PCVs was 5% in 2010. |
|
|
Disease control/elimination |
|
|
|
The global target is to achieve at least 90% diptheria, pertussis and tetanus (DPT3)-containing vaccine coverage at national level and at least 80% in every district. From 2000 to 2010, the regional average of DPT3 coverage increased from 79% to 88%.
The goal of the global immunization vision and strategy, adopted by countries of the Eastern Mediterranean Region, is to achieve by 2015, a two-thirds reduction of morbidity and mortality of vaccine-preventable diseases as compared to the level of 2000. Strengthening surveillance for vaccine-preventable diseases is fundamental for monitoring progress towards achieving this target. |
|
Disease control/elimination |
|
|
|
Rotavirus vaccines are an important measure to prevent and control severe rotavirus-associated diarrhea morbidity and mortality. The vaccine prevents about 74% of all rotavirus cases, reduced doctor visits for Rotavirus diarrhea by 86% and hospitalizations and emergency department visits by 94.5%.
Since rotavirus gastroenteritis is responsible for substantial proportion of mortality among under five years children in the Eastern Mediterranean Region, introduction of rotavirus vaccine is an important tool towards achieving the Millennium Development Goal number 4 (MDG4). The Accelerating the introduction of the rotavirus vaccine in the countries in the region is deemed necessary.
Introduction of rotavirus vaccine should also be undertaken as part of an integrated diarrheal disease control programme. |
|
|
|
|
|
|
Page 6 of 93 |
